← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,142 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
ATER
Aterian, Inc.
Valuation N/A
Consumer Cyclical
Price$0.61
Model IV—
P/IV—
Market implies +12.9%/yr
ATGL
Alpha Technology Group Ltd
Valuation N/A
Technology
Price$4.51
Model IV—
P/IV—
Market implies +40.4%/yr
ATHR
Aether Holdings, Inc.
Valuation N/A
Technology
Price$2.98
Model IV—
P/IV—
Market implies +40.9%/yr
ATIIW
Archimedes Tech SPAC Partners II Co.
Valuation N/A
Financial Services
Price$1.14
Model IV—
P/IV—
Limited data — see page
ATLN
ATLN
Valuation N/A
Price$0.75
Model IV—
P/IV—
Limited data — see page
ATLO
AMES NATIONAL CORP
Deeply overvalued
Financial Services
Price$31.46
Model IV$19.04
P/IV1.67
Premium +65% Return to IV: -39.5%
ATLX
Atlas Lithium Corp
Valuation N/A
Basic Materials
Price$2.29
Model IV—
P/IV—
Market implies +56.3%/yr vs model +5.0% · above model
ATNM
Actinium Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$1.10
Model IV—
P/IV—
Market implies +82.9%/yr
ATOM
Atomera Inc
Valuation N/A
Technology
Price$4.16
Model IV—
P/IV—
Market implies +109.7%/yr
ATOS
ATOSSA THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$2.44
Model IV—
P/IV—
Limited data — see page
ATPC
Agape ATP Corp
Deeply overvalued
Healthcare
Price$2.23
Model IV$1.03
P/IV1.97
Premium +117% Return to IV: -53.8%
Market implies +8.5%/yr vs model +10.7% · in line
ATRA
Atara Biotherapeutics, Inc.
Fairly valued
Healthcare
Price$9.48
Model IV$9.49
P/IV0.89
Discount 0% Return to IV: +0.2%
Market implies -2.5%/yr vs model +15.0% · below model
ATXG
ADDENTAX GROUP CORP.
Valuation N/A
Technology
Price$3.02
Model IV—
P/IV—
Market implies -13.0%/yr
ATYR
aTYR PHARMA INC
Valuation N/A
Healthcare
Price$0.25
Model IV—
P/IV—
Market implies +62.8%/yr
AUBN
AUBURN NATIONAL BANCORPORATION, INC
Deeply overvalued
Financial Services
Price$26.54
Model IV$18.74
P/IV1.44
Premium +42% Return to IV: -29.4%
AUC
ATIF Holdings Ltd
Valuation N/A
Industrials
Price$9.19
Model IV—
P/IV—
Market implies +93.8%/yr
AUID
authID Inc.
Fairly valued
Technology
Price$0.35
Model IV$0.34
P/IV1.21
Premium +4% Return to IV: -3.5%
Market implies +0.0%/yr vs model +35.1% · below model
AURE
Aurelion Inc.
Valuation N/A
Financial Services
Price$1.04
Model IV—
P/IV—
Market implies +43.9%/yr
AUROW
Aurora Innovation, Inc.
Valuation N/A
Technology
Price$0.03
Model IV—
P/IV—
Market implies +26.3%/yr
AUSI
AURA SYSTEMS INC
Valuation N/A
Technology
Price$0.19
Model IV—
P/IV—
Market implies +24.2%/yr vs model +29.1% · below model
AUST
Austin Gold Corp.
Valuation N/A
Basic Materials
Price$0.98
Model IV—
P/IV—
Market implies +38.7%/yr vs model +5.0% · above model
AUUD
AUDDIA INC.
Valuation N/A
Technology
Price$1.06
Model IV—
P/IV—
Limited data — see page
AVD
AMERICAN VANGUARD CORP
Valuation N/A
Basic Materials
Price$1.60
Model IV—
P/IV—
Market implies +44.3%/yr vs model +2.9% · above model
AVK
ADVENT CONVERTIBLE & INCOME FUND
Valuation N/A
Unknown
Price$11.65
Model IV—
P/IV—
Limited data — see page
AVNW
AVIAT NETWORKS, INC.
Valuation N/A
Technology
Price$20.77
Model IV—
P/IV—
Market implies +78.7%/yr
AVX
AVAX ONE TECHNOLOGY LTD.
Valuation N/A
Financial Services
Price$4.79
Model IV—
P/IV—
Market implies +73.9%/yr
AVXL
ANAVEX LIFE SCIENCES CORP.
Valuation N/A
Healthcare
Price$1.49
Model IV—
P/IV—
Limited data — see page
AWF
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC
Valuation N/A
Unknown
Price$9.60
Model IV—
P/IV—
Limited data — see page
AWRE
AWARE INC /MA/
Deeply overvalued
Technology
Price$1.04
Model IV$0.26
P/IV4.31
Premium +308% Return to IV: -75.5%
Market implies +21.5%/yr vs model +2.0% · above model
AWX
AVALON HOLDINGS CORP
Deeply overvalued
Utilities
Price$2.47
Model IV$0.75
P/IV3.31
Premium +229% Return to IV: -69.6%
AXG
Solowin Holdings, Ltd.
Deeply undervalued
Financial Services
Price$0.08
Model IV$0.71
P/IV2.29
Discount 88% Return to IV: +763.4%
Market implies -43.8%/yr vs model +50.0% · below model
AXIA
AXIA
Valuation N/A
Price$9.53
Model IV—
P/IV—
Limited data — see page
AXIL
Axil Brands, Inc.
Deeply undervalued
Consumer Defensive
Price$5.71
Model IV$12.77
P/IV0.48
Discount 55% Return to IV: +123.6%
Market implies -17.5%/yr vs model +50.0% · below model
AXIN
Axiom Intelligence Acquisition Corp 1
Valuation N/A
Financial Services
Price$10.36
Model IV—
P/IV—
Limited data — see page
AXINR
Axiom Intelligence Acquisition Corp 1
Valuation N/A
Financial Services
Price$0.17
Model IV—
P/IV—
Limited data — see page
AXINU
Axiom Intelligence Acquisition Corp 1
Valuation N/A
Financial Services
Price$10.50
Model IV—
P/IV—
Limited data — see page
AXR
AMREP CORP.
Deeply overvalued
Real Estate
Price$20.72
Model IV$15.43
P/IV1.40
Premium +34% Return to IV: -25.5%
Market implies +3.5%/yr vs model +2.0% · in line
AYTU
AYTU BIOPHARMA, INC
Overvalued
Healthcare
Price$2.03
Model IV$1.66
P/IV1.35
Premium +22% Return to IV: -18.1%
Market implies +1.6%/yr vs model +3.4% · in line
AZ
A2Z CUST2MATE SOLUTIONS CORP.
Valuation N/A
Industrials
Price$5.77
Model IV—
P/IV—
Market implies +55.0%/yr
AZI
Autozi Internet Technology (Global) Ltd.
Deeply overvalued
Industrials
Price$1.14
Model IV$0.25
P/IV4.58
Premium +362% Return to IV: -78.4%
Market implies +25.6%/yr vs model +2.0% · above model
AZTR
Azitra, Inc.
Valuation N/A
Healthcare
Price$0.13
Model IV—
P/IV—
Market implies +57.2%/yr
BACC
Blue Acquisition Corp/Cayman
Valuation N/A
Financial Services
Price$10.44
Model IV—
P/IV—
Limited data — see page
BACCR
Blue Acquisition Corp/Cayman
Valuation N/A
Financial Services
Price$0.30
Model IV—
P/IV—
Limited data — see page
BACCU
Blue Acquisition Corp/Cayman
Valuation N/A
Financial Services
Price$10.88
Model IV—
P/IV—
Limited data — see page
BAER
Bridger Aerospace Group Holdings, Inc.
Deeply undervalued
Technology
Price$0.61
Model IV$7.54
P/IV0.12
Discount 92% Return to IV: +1,145.4%
Market implies -50.0%/yr vs model +38.4% · below model
BAERW
Bridger Aerospace Group Holdings, Inc.
Valuation N/A
Technology
Price$0.08
Model IV—
P/IV—
Market implies -50.0%/yr vs model +38.4% · below model
BAFN
BayFirst Financial Corp.
Deeply undervalued
Financial Services
Price$5.38
Model IV$9.24
P/IV0.84
Discount 42% Return to IV: +71.7%
BANL
CBL International Ltd
Valuation N/A
Consumer Defensive
Price$4.23
Model IV—
P/IV—
Market implies -29.0%/yr vs model +7.5% · below model
BANX
ArrowMark Financial Corp.
Valuation N/A
Unknown
Price$19.64
Model IV—
P/IV—
Limited data — see page
BAOS
Baosheng Media Group Holdings Ltd
Deeply overvalued
Technology
Price$0.25
Model IV$0.11
P/IV2.49
Premium +121% Return to IV: -54.8%
Market implies +11.7%/yr vs model +2.0% · above model
BARK
Bark, Inc.
Undervalued
Consumer Cyclical
Price$8.02
Model IV$11.12
P/IV0.73
Discount 28% Return to IV: +38.6%
Market implies -5.6%/yr vs model +2.0% · below model
BATL
BATTALION OIL CORP
Deeply undervalued
Energy
Price$1.01
Model IV$6.89
P/IV0.16
Discount 85% Return to IV: +581.7%
Market implies -41.4%/yr vs model +0.0% · below model
BAYA
BAYA
Valuation N/A
Price$12.14
Model IV—
P/IV—
Limited data — see page
BAYAR
BAYAR
Valuation N/A
Price$0.08
Model IV—
P/IV—
Limited data — see page
BAYAU
BAYAU
Valuation N/A
Price$12.00
Model IV—
P/IV—
Limited data — see page
BBBY
BBBY
Valuation N/A
Price$1.69
Model IV—
P/IV—
Limited data — see page
BBCQ
BBCQ
Valuation N/A
Price$9.79
Model IV—
P/IV—
Limited data — see page
BBCQU
BBCQU
Valuation N/A
Price$10.09
Model IV—
P/IV—
Limited data — see page
BBCQW
BBCQW
Valuation N/A
Price$1.10
Model IV—
P/IV—
Limited data — see page
BBGI
BEASLEY BROADCAST GROUP INC
Deeply undervalued
Communication Services
Price$10.03
Model IV$50.81
P/IV0.22
Discount 80% Return to IV: +406.6%
Market implies -32.2%/yr vs model +2.0% · below model